Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20626280 | 0.76 | KDM4E (0.33) | KDM4EMEN1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL26259757 | 0.76 | KDM4E (0.33) | KDM4EMEN1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL20534467 | 0.73 | CYP1A2 (0.41) | KDM4EMEN1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL30620185 | 0.73 | CYP1A2 (0.41) | KDM4EMEN1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL26259846 | 0.72 | KDM4E (0.32) | KDM4EMEN1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL21776991 | 0.72 | NOTUM (0.44) | CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL23529810 | 0.72 | KDM4E (0.36) | KDM4EMEN1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL1571643 | 0.72 | MEN1 (0.35) | KDM4EMEN1KMT2A | |
| SCHEMBL28468438 | 0.72 | KDM4E (0.36) | KDM4EMEN1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL24373011 | 0.71 | GABRA1 (0.43) | KDM4EMEN1ALDH1A1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10418567-B2 | Organic compound for organic EL device and using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2019-09-17 | — | — | US | disclosed |
| US-10418567-B2 | Organic compound for organic EL device and using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2019-09-17 | — | — | US | disclosed |
| US-20180182978-A1 | ORGANIC COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2018-06-28 | — | — | US | disclosed |
| US-20180182978-A1 | ORGANIC COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2018-06-28 | — | — | US | disclosed |
| US-20180182978-A1 | ORGANIC COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2018-06-28 | — | — | US | disclosed |
| EP-2368892-B1 | NOVEL COMPOUND, PROCESS FOR PRODUCING THE COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC SEMICONDUCTOR DEVICE | UNIV HIROSHIMA (JP) | 2014-12-03 | — | — | EP | disclosed |
| EP-2368892-B1 | NOVEL COMPOUND, PROCESS FOR PRODUCING THE COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC SEMICONDUCTOR DEVICE | UNIV HIROSHIMA (JP) | 2014-12-03 | — | — | EP | disclosed |
| US-8816100-B2 | Compound, method of producing the compound, organic semiconductor material and organic semiconductor device | HIROSHIMA UNIVERSITY (JP) | 2014-08-26 | — | — | US | disclosed |
| US-8816100-B2 | Compound, method of producing the compound, organic semiconductor material and organic semiconductor device | HIROSHIMA UNIVERSITY (JP) | 2014-08-26 | — | — | US | disclosed |
| US-8816100-B2 | Compound, method of producing the compound, organic semiconductor material and organic semiconductor device | HIROSHIMA UNIVERSITY (JP) | 2014-08-26 | — | — | US | disclosed |
| US-20140051865-A1 | DESCRIPTION NOVEL COMPUND, METHOD OF PRODUCING THE COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL AND ORGANIC SEMICONDUCTOR DEVICE | HIROSHIMA UNIVERSITY (JP) | 2014-02-20 | — | — | US | disclosed |
| US-20140051865-A1 | DESCRIPTION NOVEL COMPUND, METHOD OF PRODUCING THE COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL AND ORGANIC SEMICONDUCTOR DEVICE | HIROSHIMA UNIVERSITY (JP) | 2014-02-20 | — | — | US | disclosed |
| EP-2368892-A1 | NOVEL COMPOUND, PROCESS FOR PRODUCING THE COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC SEMICONDUCTOR DEVICE | Hiroshima University (JP) | 2011-09-28 | — | — | EP | disclosed |
| US-20110224445-A1 | Novel Compound, Method of Producing the Compound, Organic Semiconductor Material and Organic Semiconductor Device | HIROSHIMA UNIVERSITY (JP) | 2011-09-15 | — | — | US | disclosed |
| US-20110224445-A1 | Novel Compound, Method of Producing the Compound, Organic Semiconductor Material and Organic Semiconductor Device | HIROSHIMA UNIVERSITY (JP) | 2011-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10418567-B2 | Organic compound for organic EL device and using the same | EML4, LEF1, ELOB | KDM4E 1540/4885MEN1 1612/4885ALDH1A1 1274/4885 |
| US-20110224445-A1 | Novel Compound, Method of Producing the Compound, Organic Semiconductor Material and Organic Semiconductor Device | TST, SCLY, SELENOI | KDM4E 2648/4885MEN1 1372/4885ALDH1A1 2258/4885 |
| US-20180182978-A1 | ORGANIC COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME | EML4, LEF1, ELOB | KDM4E 1540/4885MEN1 1612/4885ALDH1A1 1274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.